Sonnet BioTherapeutics Holdings, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$3.51M, a 11.2% increase year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$7.99M, a 64.7% increase year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$18.8M, a 36.6% increase from 2022.
  • Sonnet BioTherapeutics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$29.7M, a 19% decline from 2021.
  • Sonnet BioTherapeutics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$25M, a 2.96% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$7.99M -$3.51M +$441K +11.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$8.43M $365K +$6.03M Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-14
Q4 2023 -$14.5M -$1.17M +$4.37M +78.9% Oct 1, 2023 Dec 31, 2023 10-Q 2024-08-14
Q3 2023 -$18.8M -$3.68M +$3.76M +50.6% Jul 1, 2023 Sep 30, 2023 10-K 2023-12-14
Q2 2023 -$22.6M -$3.95M +$3.93M +49.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$26.5M -$5.67M +$2.54M +31% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-14
Q4 2022 -$29.1M -$5.54M +$659K +10.6% Oct 1, 2022 Dec 31, 2022 10-Q 2024-08-14
Q3 2022 -$29.7M -$7.44M -$483K -6.95% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-14
Q2 2022 -$29.2M -$7.88M -$1.76M -28.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$27.5M -$8.21M -$2.17M -35.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-14
Q4 2021 -$25.3M -$6.2M -$324K -5.51% Oct 1, 2021 Dec 31, 2021 10-Q 2023-08-14
Q3 2021 -$25M -$6.95M +$568K +7.56% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-15
Q2 2021 -$25.6M -$6.12M +$5.66M +48.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$31.2M -$6.04M -$3.54M -142% Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-15
Q4 2020 -$27.7M -$5.88M -$3.41M -138% Oct 1, 2020 Dec 31, 2020 10-Q 2022-08-15
Q3 2020 -$24.3M -$7.52M -$3.64M -93.6% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-17
Q2 2020 -$20.6M -$11.8M -$10.4M -732% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$10.3M -$2.5M -$2.21M -780% Jan 1, 2020 Mar 31, 2020 10-Q 2021-08-16
Q4 2019 -$8.05M -$2.47M -$2.18M -745% Oct 1, 2019 Dec 31, 2019 10-Q 2021-08-16
Q3 2019 -$5.88M -$3.88M -$2.65M -214% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q2 2019 -$3.23M -$1.42M -$656K -86.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$2.57M -$284K +$2.31M +89.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-08-14
Q4 2018 -$4.89M -$292K +$1.12M +79.3% Oct 1, 2018 Dec 31, 2018 10-Q 2020-08-14
Q3 2018 -$6.01M -$1.24M +$473K +27.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$6.48M -$760K +$1.19M +60.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$7.67M -$2.6M -$870K -50.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$6.79M -$1.41M +$284K +16.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$7.08M -$1.71M -$807K -89.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$6.27M -$1.95M +$3.11M +61.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$9.38M -$1.73M -$302K -21.2% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 -$9.08M -$1.69M +$102K +5.68% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 -$9.18M -$904K +$3.61M +80% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$12.8M -$5.05M -$1.5M -42.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$11.3M -$1.43M +$843K +37.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$12.1M -$1.8M +$2.05M +53.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$14.2M -$4.52M -$3.97M -719% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$10.2M -$3.56M -$3M -545% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$7.22M -$2.27M -$818K -56.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$6.4M -$3.85M -$1.5M -64.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-31
Q3 2014 -$4.9M -$551K +$872K +61.3% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-14
Q2 2014 -$5.77M -$551K +$156K +22% Apr 1, 2014 Jun 30, 2014 10-Q 2015-11-16
Q1 2014 -$5.93M -$1.45M -$712K -96.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-20
Q4 2013 -$5.21M -$2.35M -$1.47M -167% Oct 1, 2013 Dec 31, 2013 10-K 2015-04-15
Q3 2013 -$3.75M -$1.42M -$684K -92.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$3.06M -$707K +$137K +16.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$3.2M -$738K -$34.1K -4.84% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$3.17M -$879K -$213K -31.9% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$2.95M -$740K -$244K -49.2% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-15
Q2 2012 -$2.71M -$844K -$618K -273% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 -$2.09M -$704K -$929K -412% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$1.16M -$667K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-03
Q3 2011 -$496K -$346K -232% Jul 1, 2011 Sep 30, 2011 10-Q/A 2012-12-31
Q2 2011 -$226K -$112K -98% Apr 1, 2011 Jun 30, 2011 10-Q/A 2013-01-02
Q1 2011 $226K Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-12-28
Q3 2010 -$149K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$114K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.